E. Gunn

529 total citations
11 papers, 199 citations indexed

About

E. Gunn is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, E. Gunn has authored 11 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 1 paper in Infectious Diseases and 1 paper in Surgery. Recurrent topics in E. Gunn's work include Cystic Fibrosis Research Advances (5 papers), Neonatal Respiratory Health Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). E. Gunn is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Neonatal Respiratory Health Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). E. Gunn collaborates with scholars based in United Kingdom, Canada and United States. E. Gunn's co-authors include Diana Bilton, S.B. Carr, Sanja Stanojevic, Mike Scott, Juliet Compston, Rebecca Cosgriff, Charles Haworth, Daniela K Schlüter, Ruth H. Keogh and Amy MacDougall and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, International Journal of Epidemiology and Thorax.

In The Last Decade

E. Gunn

10 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Gunn United Kingdom	5	168	33	20	14	12	11	199
Morgane Didier France	6	131 0.8×	84 2.5×	20 1.0×	12 0.9×	4 0.3×	22	254
Seth Walker United States	6	366 2.2×	28 0.8×	32 1.6×	11 0.8×	3 0.3×	13	398
Rebecca Cosgriff United Kingdom	8	144 0.9×	13 0.4×	45 2.3×	48 3.4×	20 1.7×	16	250
Anne Des Roches Canada	10	56 0.3×	75 2.3×	12 0.6×	21 1.5×	13 1.1×	30	431
Divya Patel United States	7	128 0.8×	86 2.6×	25 1.3×	22 1.6×	3 0.3×	53	183
Montserrat Bosque Spain	9	173 1.0×	93 2.8×	21 1.1×	71 5.1×	3 0.3×	19	240
Shigeko Kojima Japan	7	65 0.4×	46 1.4×	149 7.5×	15 1.1×	3 0.3×	13	270
Jessica Ryan Australia	8	51 0.3×	5 0.2×	36 1.8×	27 1.9×	4 0.3×	11	201
Youn Ho Shin South Korea	5	49 0.3×	114 3.5×	19 0.9×	11 0.8×	2 0.2×	12	256
Suzan A. AlKhater Saudi Arabia	8	30 0.2×	44 1.3×	45 2.3×	9 0.6×		20	185

Countries citing papers authored by E. Gunn

Since Specialization

Citations

This map shows the geographic impact of E. Gunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gunn more than expected).

Fields of papers citing papers by E. Gunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gunn. The network helps show where E. Gunn may publish in the future.

Co-authorship network of co-authors of E. Gunn

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gunn. A scholar is included among the top collaborators of E. Gunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gunn. E. Gunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Mahmoud, Sherif Hanafy, et al.. (2025). Pharmacotherapy variability and precision medicine in neurocritical care. Frontiers in Neurology. 16. 1630163–1630163.

Mason, Michael J., Vanessa Soares Lara, John F. Brown, et al.. (2025). Prehospital Buprenorphine in Treating Symptoms of Opioid Withdrawal – A Descriptive Review of the First 131 Cases in San Francisco, CA. Prehospital Emergency Care. 29(4). 435–440. 2 indexed citations

Gunn, E., N Caine, Rebecca Cosgriff, Susan C. Charman, & S.B. Carr. (2019). P082 UK Cystic Fibrosis Registry data validation programme. Journal of Cystic Fibrosis. 18. S80–S81. 2 indexed citations

Cosgriff, Rebecca, et al.. (2019). P085 Investigating time between annual review encounters in the UK Cystic Fibrosis Registry. Journal of Cystic Fibrosis. 18. S81–S82. 1 indexed citations

Taylor‐Robinson, David, S.B. Carr, Rebecca Cosgriff, et al.. (2017). Data Resource Profile: The UK Cystic Fibrosis Registry. International Journal of Epidemiology. 47(1). 9–10e. 68 indexed citations

Gunn, E., et al.. (2015). ePS02.8 Prevalence and clinical associations of fungal airway isolates in the UK adult cystic fibrosis population. Journal of Cystic Fibrosis. 14. S45–S45. 5 indexed citations

Goss, Christopher H., Stephanie MacNeill, Hebe B. Quinton, et al.. (2014). Children and young adults with CF in the USA have better lung function compared with the UK. Thorax. 70(3). 229–236. 42 indexed citations

Stanojevic, Sanja, Janet Stocks, Vassiliki Bountziouka, et al.. (2013). The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF Registry. Journal of Cystic Fibrosis. 13(3). 319–327. 33 indexed citations

Aurora, P., Sanja Stanojevic, Janet Stocks, et al.. (2013). WS12.2 The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry. Journal of Cystic Fibrosis. 12. S24–S24. 1 indexed citations

10.

Wildman, Martin J, et al.. (2011). P236 Cystic Fibrosis deaths in USA and UK: comparisons of registry and routine data. Thorax. 66(Suppl 4). A163–A164. 1 indexed citations

11.

Haworth, Charles, et al.. (2006). Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 174(3). 306–311. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact